41 APPU RATHINAVELU, PH.D. Professor and Director, NSU Rumbaugh-Goodwin Institute for Cancer Research (RGI) NSU Barry and Judy Silverman College of Pharmacy NSU Rumbaugh-Goodwin Institute for Cancer Research PATENTS/AVAILABLE TECHNOLOGIES a) Therapeutics: anti-VEGF small molecule for treating solid tumors (U.S. patent issued on January 25, 2011, and May 10, 2016.) b) Therapeutics: anti-VEGF small molecule for treating glioblastoma (Provisional patent application filed November 14, 2019.) a) b) c) c) Therapeutics: inhibitor of VEGF for treating cancer (Patents granted in the United States, Canada, Europe, Japan, and Korea.) Umamaheswri Natarajan, Ph.D. Jayanta Das, Ph.D. Postdoctoral Research Scholar, RGI Mahmood Mansoor S. Algahtani Doctoral Student NSU College of Psychology FELLOW INVENTORS JEAN J. LATIMER, PH.D. Director, NSU AutoNation Institute for Breast Cancer Research and Care, and Associate Professor NSU Barry and Judy Silverman College of Pharmacy NSU AutoNation Institute for Breast Cancer Research and Care PATENTS/AVAILABLE TECHNOLOGIES d) Therapeutics: regulation of nucleotide excision repair (NER) by MicroRNA for treating breast cancer (Provisional patent application submitted March 8, 2019.) e) Medical Devices and Diagnostics: method for detection of mutation in glycophorin A and prediction of exposure to mutagens (U.S. patent issued on June 16, 2020.) Stephen Grant, Ph.D. Dr. Kiran C. Patel College of Osteopathic Medicine d) e) FELLOW INVENTOR HUMAN DISEASE: THE FRONT LINE NOVA S OU T H E AS T E RN UN I V E R S I T Y
RkJQdWJsaXNoZXIy NDE4MDg=